FDA Inspection 635541 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA completed an inspection of IPR Pharmaceuticals, Inc. on December 21, 2009 in Canovanas, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 21, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)